Posted on April 23rd, 2012, 4:01 pm
Wall St. Cheat Sheet InterMune is a biotech company, which is focused on developing and commercializing innovative therapies in pulmonology and hepatology. . Wall St. Earnings Expectations: The average estimate of analysts is for a loss of 71 cents per share, ... |